Skip to main content
main-content

Onkologie und Hämatologie | Zeitschrift

memo - Magazine of European Medical Oncology

memo - Magazine of European Medical Oncology 2/2021

Ausgabe 2/2021

Inhaltsverzeichnis ( 20 Artikel )

01.06.2021 | editorial | Ausgabe 2/2021

Immunotherapy revisited

Assoc. Prof. PD Dr. Thorsten Füreder

01.06.2021 | editorial | Ausgabe 2/2021

Treatment approaches towards physical activity – malnutrition – cognitive impairment

PD Dr. Marlene Troch

01.06.2021 | editorial | Ausgabe 2/2021

European Society for Medical Oncology 2020

Dr. Rupert Bartsch

01.06.2021 | editorial | Ausgabe 2/2021

Neuro-oncology 2021

Dr. med. Silvia Hofer

04.05.2021 | editorial | Ausgabe 2/2021

memo—publisher’s report 2020

Dr. Alois Sillaber

31.03.2021 | short review | Ausgabe 2/2021 Open Access

Novel immune checkpoints beyond PD-1 in advanced melanoma

Nina Zila, Christoph Hoeller, Verena Paulitschke

08.04.2021 | review | Ausgabe 2/2021 Open Access

CAR T cell therapy in solid tumors: a short review

Öykü Umut M.D., Adrian Gottschlich M.D., Stefan Endres M.D., Sebastian Kobold M.D.

31.03.2021 | short review | Ausgabe 2/2021 Open Access

DNA methylation as predictive marker of response to immunotherapy?

Gerwin Heller PhD, MSc.

24.03.2021 | review | Ausgabe 2/2021 Open Access

Importance of performance status and physical activity in cancer patients

Dr. David Kiesl

05.03.2021 | review | Ausgabe 2/2021

Cognitive impairment in cancer patients and survivors—clinical presentation, pathophysiology, diagnosis and management

Markus Hutterer MD, Stefan Oberndorfer

01.04.2021 | short review | Ausgabe 2/2021 Open Access

Malnutrition and cancer, diagnosis and treatment

Mag. Angelika Beirer Bsc.

31.03.2021 | short review | Ausgabe 2/2021 Open Access

ESMO virtual congress 2020—highlights NSCLC

Barbara Kiesewetter

01.04.2021 | short review | Ausgabe 2/2021 Open Access

ESMO 2020 update: Pancreatic cancer

Elisabeth Sophie Bergen MD, PhD

08.04.2021 | original report | Ausgabe 2/2021

Update ESMO: gastric and esophageal cancer

Ulrich Popper MD, Holger Rumpold MD

30.04.2021 | short review | Ausgabe 2/2021 Open Access

ESMO 2020: highlights in breast cancer

Rupert Bartsch

12.02.2021 | short review | Ausgabe 2/2021 Open Access

WHO classification of tumors of the nervous system: preview of the upcoming 5th edition

Elisabeth J. Rushing

16.03.2021 | short review | Ausgabe 2/2021 Open Access

Leptomeningeal metastases from solid tumours

Silvia Hofer, Emilie Le Rhun

22.05.2021 | short review | Ausgabe 2/2021 Open Access

Brain metastases: new systemic treatment approaches

Ariane Steindl MD PhD, Anna Sophie Berghoff

07.05.2021 | short review | Ausgabe 2/2021 Open Access

Are there still indications for whole brain irradiation in 2021?

Karin Dieckmann, Harald Herrmann

04.05.2021 | case report | Ausgabe 2/2021

Unique gastrointestinal stromal tumor with PDGFRA D842Y mutation—evaluation of in vivo sensitivity to imatinib

Olga Kuczkiewicz-Siemion, Agnieszka Dansonka-Mieszkowska, Piotr Rutkowski, Anna Klimczak, Andrzej Tysarowski, Monika Prochorec-Sobieszek, Anna Szumera-Ciećkiewicz

Aktuelle Ausgaben